MedPath

Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)).

Phase 1
Completed
Conditions
Sexual Dysfunction, Physiological
Interventions
Device: Vaginal Heat Wash-Out Device
Registration Number
NCT00443248
Lead Sponsor
Pfizer
Brief Summary

The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Output data are collected on a PC. By measuring the clearance of heat from the heated probe, a direct measure of absolute blood flow can be obtained. The study will assess the technique's ability to differentiate between pre- and post-menopausal women; with and without Female Sexual Arousal Disorder (FSAD).

Detailed Description

Medical Device Development

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
64
Inclusion Criteria
  • Pre-menopausal women aged 18-40 (with and without FSAD) or
  • Post-menopausal women aged 50-65 (with and without FSAD.
  • FSAD must have been present for at least 6 months.
Read More
Exclusion Criteria
  • Pregnant or lactating women (pre-menopausal population)
  • Systemic Hormone Replacement Therapy (HRT) or Selective Estrogen Receptor Modulator (SERM) (postmenopausal population)
  • Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic disease or other major psychological or sexual disorder.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Vaginal Heat Wash-Out DeviceVaginal Heat Wash-Out Device-
Primary Outcome Measures
NameTimeMethod
To assess the safety and toleration of the heat washout device.2 weeks
To investigate differences in vaginal blood flow following visual sexual stimulation in pre-menopausal women with and without FSAD.2 weeks
Secondary Outcome Measures
NameTimeMethod
To investigate changes in subjective acute sexual arousal following visual sexual stimulation in women with and without FSAD.2 weeks

Trial Locations

Locations (1)

Pfizer Investigational Site

🇦🇺

Nedlands, Western Australia, Australia

© Copyright 2025. All Rights Reserved by MedPath